Home / Recalls / Loud Muscle Science / D-1338-2022

D-1338-2022 Class I Terminated

Recalled by Loud Muscle Science — Hauppauge, NY

Recall Details

Product Type
Drugs
Report Date
July 27, 2022
Initiation Date
June 27, 2022
Termination Date
February 8, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
500 4-count tins

Product Description

Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.

Reason for Recall

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

Distribution Pattern

The product was distributed nationwide in the USA and Canada.

Code Information

Lot # 2022104, exp. date 04/2025

Other recalls by Loud Muscle Science

  • D-1337-2022 Class I — Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661 (June 27, 2022)
  • D-1339-2022 Class II — Launch Sequence Capsules, Dietary Supplement, 60- count bottles, ASIN B07TLPWXDS (June 27, 2022)
  • D-1336-2022 Class I — Launch Sequence Capsules, Dietary Supplement, 60- count bottles, ASIN B07TLPWXDS (June 27, 2022)
  • D-1340-2022 Class II — Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661 (June 27, 2022)
  • D-1341-2022 Class II — Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661 (June 27, 2022)